Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar 29:17:168.
doi: 10.1186/s13063-016-1302-8.

Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial

Affiliations
Randomized Controlled Trial

Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial

José Fernando Vilela-Martin et al. Trials. .

Abstract

Background: Resistant hypertension (RH) treatment requires an adequate and intense therapeutic approach. However, the results are not always satisfactory despite intensive treatment. Of the different pathophysiological mechanisms involved in the pathogenesis of RH, sympathetic overstimulation and therapies that block the sympathetic system have been widely studied. These approaches, however, are invasive and expensive. Another possible approach is by transcutaneous electrical nerve stimulation (TENS), a noninvasive method that modulates activity by using low-frequency transcutaneous electrical stimulation to inhibit primary afferent pathways. Thus, the current study will evaluate the effect of applying TENS in the cervicothoracic region of subjects with RH and will seek to develop a new low-cost and readily available therapy to treat this group of hypertensive individuals.

Methods/design: This is a randomized, single blind (subject), parallel-assignment study controlled with a sham group and including participants aged 40 to 70 years with resistant hypertension. The trial has two arms: the treatment and control (sham group). The treatment group will be submitted to the stimulation procedure (TENS). The sham group will not be submitted to stimulation. The primary outcomes will be a reduction in the peripheral blood pressure and adverse events. The secondary outcomes will be a reduction the central blood pressure. The study will last 30 days. The sample size was calculated assuming an alpha error of 5 % to reject the null hypothesis with a statistical power of 80 %, thereby resulting in 28 participants per group (intervention versus sham).

Discussion: In recent decades, RH has become very common and costly. Adequate control requires several drugs, and in many cases, treatment is not successful. Sympathetic nervous system inhibition by renal denervation and central inhibition have significant effects in reducing BP; however, these treatments are costly and invasive. Another type of sympathetic nervous system inhibition can also be noninvasively achieved by electric current. Therefore, the application of TENS may be a new therapeutic option for treating resistant hypertensive individuals.

Trial registration: Clinical Trials NCT02365974.

Keywords: Arterial stiffness; Blood pressure; Resistant hypertension; Sympathetic system; Transcutaneous electrical nerve stimulation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of study
Fig. 2
Fig. 2
Diagram showing the location for application of the transcutaneous electrical nerve stimulation (TENS)

Similar articles

Cited by

References

    1. Brazilian Society of Cardiology, Brazilian Society of Hypertension, Brazilian Society of Nephrology VI Brazilian guidelines on hypertension. Arq Bras Cardiol. 2010;95(1 Supl 1):1–51.
    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322. doi: 10.1161/CIR.0000000000000152. - DOI - PubMed
    1. Oppenheimer GM. Framingham heart study: the first 20 years. Prog Cardiovasc Dis. 2010;53:55–61. doi: 10.1016/j.pcad.2010.03.003. - DOI - PubMed
    1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association. Hypertension. 2008;51:1403–19. doi: 10.1161/HYPERTENSIONAHA.108.189141. - DOI - PubMed
    1. Pimenta E, Calhoun DA. Resistant hypertension: incidence, prevalence and prognosis. Circulation. 2012;125(13):1635–42. doi: 10.1161/CIRCULATIONAHA.112.097345. - DOI - PMC - PubMed

Publication types

Substances

Associated data